Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial

Background To compare intermittent treatment (IT) versus continuous treatment (CT) using cyproterone acetate (CPA) in bone metastatic prostate cancer patients, we conducted an open-label, multicenter randomized trial. Continuous androgen deprivation therapy is the standard treatment in metastatic pr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of urology 2014-10, Vol.32 (5), p.1287-1294
Hauptverfasser:	Verhagen, Paul C. M. S., Wildhagen, Mark F., Verkerk, Annet M., Vjaters, Egils, Pagi, Hembo, Kukk, Leonhard, Bratus, Dejan, Fiala, Richard, Bangma, Chris H., Schröder, Fritz H., Mickisch, Gerald H. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Androgen Antagonists - administration & dosage Bone Neoplasms - drug therapy Bone Neoplasms - secondary Cyproterone Acetate - administration & dosage Humans Male Medicine Medicine & Public Health Nephrology Oncology Original Article Prostatic Neoplasms - pathology Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!